TAGATOSE
Molecular Excipient
| Mwt. | LogP | HBD | HBA | PSA | RB | CSP3 |
|---|---|---|---|---|---|---|
| 180.0 | -3.4 | 5 | 6 | 118.0 | 5 | 0.83 |
- CAS
- 87810
- UNII
- T7A20Y888Y
- SYNONYMS
-
- ZINC ID(s)
- Availability
- Present in 48 ZINC catalogs
Known Active Genes
There has not been any activity reported at 10μM or less for this excipient (per ChEBML)
Clinical Trials
This compound has been an intervention in the following clincial trials (per clinicaltrials.gov).
| Code | Date | Title | Phase | Status |
|---|---|---|---|---|
| NCT00961662 | 2008-02-01 | A Clinical Study to Evaluate the Effect of Naturlose (Tagatose) | Phase 2 | Completed |
| NCT00955747 | 2007-04-01 | Naturlose (D-Tagatose) Efficacy Evaluation Trial | Phase 3 | Completed |